Morphosys AG (MORG.DE)

MORG.DE on Xetra

68.27EUR
15 Aug 2014
Price Change (% chg)

€-1.71 (-2.44%)
Prev Close
€69.98
Open
€70.05
Day's High
€70.87
Day's Low
€68.09
Volume
72,913
Avg. Vol
66,997
52-wk High
€74.90
52-wk Low
€50.24

MORG.DE

Chart for MORG.DE

About

Morphosys AG is a German biotechnology company focused on generation of fully human antibodies. It operates two business segments: Partnered Discovery and Proprietary Development. The Partnered Discovery business segment comprises technologies for the generation of human antibody therapeutics, which is exploited via partnerships... (more)

Overall

Beta: 0.30
Market Cap (Mil.): €1,863.49
Shares Outstanding (Mil.): 26.37
Dividend: --
Yield (%): --

Financials

  MORG.DE Industry Sector
P/E (TTM): -- 139.05 34.44
EPS (TTM): -0.20 -- --
ROI: -1.60 -2.96 18.11
ROE: -1.77 -7.10 18.84
Search Stocks

BRIEF-Morphosys shares rise after Q2 results

July 28 - Shares in Morphosys AG rise 2.6 percent at open after Q2 results

28 Jul 2014

BRIEF-Morphosys affirms outlook after Q2 loss

July 28 - Morphosys AG : * Says H1 revenues from continuing operations were EUR 30.5 million (H1 2013:

28 Jul 2014

BRIEF-Morphosys enters strategic immuno-oncology collaboration with Merck Serono

FRANKFURT, June 12 - Morphosys AG : * Says enters strategic immuno-oncology collaboration * Says Morphosys and Merck Serono enter strategic immuno-oncology collaboration

12 Jun 2014

BRIEF-Morphosys-MOR208 receives orphan drug status from FDA, EMA to treat of cll/sll

FRANKFURT, May 20 - Morphosys AG : * Says mor208 program to receive orphan drug designation from FDA and ema for

20 May 2014

BRIEF-Morphosys shares rise 3.1 percent in early trade after results

FRANKFURT, April 29 - Morphosys AG : * Shares rise 3.1 percent in early trade after results

29 Apr 2014

BRIEF-Morphosys Q1 net profit 1.1 mln euros

FRANKFURT, April 29 - Morphosys AG : * Says group revenues decreased by 6% to EUR 15.9 million compared to the same

29 Apr 2014

BRIEF-Morphosys to buy back up to 111,000 own shares

FRANKFURT, March 3 - Morphosys AG : * Says to repurchase up to 111,000 of its own shares over the stock market * Says to repurchase shares during the time period from 4 March 2014 to 28

03 Mar 2014

BRIEF-Morphosys sees 2014 EBIT loss due to fewer one-off payments

FRANKFURT, Feb 28 - Morphosys AG : * Says group revenues from continuing operations amounted to EUR 78.0 million * Says earnings before interest and taxes (EBIT) reached EUR 9.9 million * Says group revenues will decrease in 2014 * Sees consolidated net profit amounted to EUR 13.3 million * Says sees revenues 58-63 million EUR, an EBIT in the range of EUR -11 to EUR

28 Feb 2014

Earnings vs. Estimates

Search Stocks